Mrs Andree Levorsen

(Norway)

Follow

Contributor content

$Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome$

Presentation

Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources